Viewing Study NCT00091156


Ignite Creation Date: 2025-12-24 @ 11:15 PM
Ignite Modification Date: 2026-02-23 @ 6:25 AM
Study NCT ID: NCT00091156
Status: TERMINATED
Last Update Posted: 2012-07-16
First Post: 2004-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module